SK149294A3 - Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production - Google Patents

Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production Download PDF

Info

Publication number
SK149294A3
SK149294A3 SK1492-94A SK149294A SK149294A3 SK 149294 A3 SK149294 A3 SK 149294A3 SK 149294 A SK149294 A SK 149294A SK 149294 A3 SK149294 A3 SK 149294A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
acid
methyl
dihydro
Prior art date
Application number
SK1492-94A
Other languages
English (en)
Slovak (sk)
Inventor
Werner Mederski
Dieter Dorsch
Mathias Osswald
Norbert Beier
Pierre Schelling
Klaus-Otto Minck
Inge Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK149294A3 publication Critical patent/SK149294A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1492-94A 1993-12-06 1994-12-05 Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production SK149294A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341453A DE4341453A1 (de) 1993-12-06 1993-12-06 Imidazopyridine

Publications (1)

Publication Number Publication Date
SK149294A3 true SK149294A3 (en) 1995-07-11

Family

ID=6504241

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1492-94A SK149294A3 (en) 1993-12-06 1994-12-05 Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production

Country Status (16)

Country Link
US (1) US5532276A (xx)
EP (1) EP0657452A1 (xx)
JP (1) JPH07196656A (xx)
KR (1) KR950018006A (xx)
CN (1) CN1109056A (xx)
AU (1) AU7919094A (xx)
CA (1) CA2137213A1 (xx)
CZ (1) CZ304694A3 (xx)
DE (1) DE4341453A1 (xx)
HU (1) HUT72595A (xx)
NO (1) NO944689L (xx)
PL (1) PL306127A1 (xx)
RU (1) RU94042907A (xx)
SK (1) SK149294A3 (xx)
TW (1) TW294665B (xx)
ZA (1) ZA949664B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798364A (en) * 1992-03-26 1998-08-25 Merck Patent Gesellschaft Mit Beschrankter Haftung Imidazopyridines
US6348380B1 (en) * 2000-08-25 2002-02-19 Micron Technology, Inc. Use of dilute steam ambient for improvement of flash devices
GEP20063937B (en) * 2002-02-14 2006-10-10 Pharmacia Corp Substituted pyridinones as modulators of p38 map kinase
ATE335744T1 (de) * 2002-08-07 2006-09-15 Novartis Pharma Gmbh Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen
JP4887139B2 (ja) 2003-03-25 2012-02-29 武田薬品工業株式会社 ジペプチジルペプチダーゼインヒビター
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
RU2006107553A (ru) 2003-08-13 2007-09-20 Такеда Фармасьютикал Компани Лимитед (Jp) Производные 4-пиримидона и их применение в качестве ингибиторов пептидилпептидаз
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1699777B1 (en) 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
NZ549716A (en) 2004-03-15 2010-04-30 Takeda Pharmaceutical Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors
WO2005118555A1 (en) 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
CA2577782A1 (en) * 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as pai-1 inhibitors
US7754747B2 (en) 2004-08-23 2010-07-13 Wyeth Llc Oxazolo-naphthyl acids
US7605172B2 (en) 2004-08-23 2009-10-20 Wyeth Thiazolo-naphthyl acids
WO2006068978A2 (en) 2004-12-21 2006-06-29 Takeda Pharmaceutial Company Limited Dipeptidyl peptidase inhibitors
NZ566799A (en) 2005-09-14 2011-04-29 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
JP5627453B2 (ja) * 2008-03-31 2014-11-19 株式会社レナサイエンス プラスミノーゲンアクチベーターインヒビター−１阻害剤
DK2607348T3 (da) 2009-03-31 2021-05-25 Renascience Inc Inhibitor af plasminogenaktivatorinhibitor-1
WO2014171464A1 (ja) 2013-04-15 2014-10-23 株式会社レナサイエンス Ｐａｉ－１阻害剤の新規用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5332750A (en) * 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
DE4141788A1 (de) * 1991-12-18 1993-06-24 Merck Patent Gmbh Imidazopyridine
DE4208304A1 (de) * 1992-03-16 1993-09-23 Merck Patent Gmbh 2-oxochinolinderivate
DE4211474A1 (de) * 1992-04-06 1993-10-07 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine
DE4225835A1 (de) * 1992-08-05 1994-02-10 Merck Patent Gmbh Verfahren zur Herstellung von Imidazopyridinen
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
KR950018006A (ko) 1995-07-22
NO944689D0 (no) 1994-12-05
CN1109056A (zh) 1995-09-27
NO944689L (no) 1995-06-07
US5532276A (en) 1996-07-02
CZ304694A3 (en) 1995-08-16
DE4341453A1 (de) 1995-06-08
PL306127A1 (en) 1995-06-12
HU9403451D0 (en) 1995-02-28
JPH07196656A (ja) 1995-08-01
EP0657452A1 (de) 1995-06-14
AU7919094A (en) 1995-06-15
HUT72595A (en) 1996-05-28
ZA949664B (en) 1995-08-15
TW294665B (xx) 1997-01-01
CA2137213A1 (en) 1995-06-07
RU94042907A (ru) 1996-10-20

Similar Documents

Publication Publication Date Title
SK149294A3 (en) Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production
SK57893A3 (en) Imidazopyridine derivatives, process for their preparation and pharmaceutical compositions
CZ287394A3 (en) Imadazopyridazines, process of their preparation and pharmaceutical compositions based thereon and process for preparing thereof
AU746586B2 (en) Quinazolinone inhibitors of cGMP phosphodiesterase
SK143593A3 (en) Imidazopyridines
US5242928A (en) Imidazopyridines
IE83625B1 (en) Imidazopyridine
SK57793A3 (en) Benzimidazole derivatives process for their preparation and their pharmaceutical compositions
HU221010B1 (hu) Imidazo-piridin-származékok és az ezeket tartalmazó gyógyászati készítmények, valamint eljárás előállításukra
NZ325248A (en) Quinoline and quinazoline compounds useful in therapy
NO318609B1 (no) Kinolin- og kinazolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
SK67794A3 (en) Imidazopyridines
CZ58193A3 (en) Derivatives of imidazopyridine, process of their preparation and pharmaceutical preparations based thereon
JPH05186462A (ja) 複素環式化合物、その製造方法および該化合物を含有する高血圧症およびうつ血性心麻痺用の医薬調剤
US5405964A (en) Imidazopyridines
NO924745L (no) Benzofuraner
SK128594A3 (en) 1,2-dihydro-2-oxopyridines
CZ166793A3 (en) Diazinediones, optionally triazinediones, process of their preparation and pharmaceutical preparations in which they are comprised